“The data we will publish today and next week demonstrate the vaccine effectiveness against SARS CoV-2 infection is waning,” CDC DirectorRochelle Walenskysaid during a press briefing. “And even though our vaccines are currently working well to prevent hospitalizations, we are seeing conce...
Pfizer has said its maternal vaccine couldpreventup to 16,000 hospitalizations and more than 300,000 visits to the doctor due to RSV if the shot becomes available in the U.S. this fall and winter. "This fall marks the start of the annual respiratory infection season in the Northern He...
Thompson, Dennis
Last year, RSV alsoappeared earlier than usual, spiking in October before declining in November. At the time,experts told ABC Newsthat this might have occurred because children were not exposed to potential infection between 2020 and 2022 due to lockdowns, or because they were...
CDC trusts Merck vaccine to prevent common infant intestinal infectionDUNSTAN PRIAL, STAFF WRITER
its age extension application through the FDA approval process. The agency is currently reviewing an application from Pfizer to extend the license for its RSV vaccine, Abrysvo, to include adults 18 and older who have health conditions that put them at risk of severe illness from RSV infection....
Those who didn't obtain that vaccine can ask their doctor about the MenACWY or the Serogroup B meningococcal (MenB) vaccine. Those at increased risk of bacterial infection should seriously consider vaccination, as it combats the five major bacteria strains that cause meningococcal disease. ...
vaccination and 77.3% mid-way through the second year after vaccination. Pfizer’s vaccine showed an efficacy of nearly 89% against RSV lower respiratory tract infection involving at least three symptoms in the first year after vaccination, and 78.6% efficacy mid-way through a second RSV season....
Those who didn't obtain that vaccine can ask their doctor about the MenACWY or the Serogroup B meningococcal (MenB) vaccine. Those at increased risk of bacterial infection should seriously consider vaccination, as it combats the five major bacteria strains that cause meningococcal disease. ...
when the vaccine can be given — during the period of September to January to protect babies born between October and March, when the risk of RSV infection is traditionally highest. The Pfizer vaccine would not be recommended for use in most of the continental U.S. from February to August....